![]() |
市场调查报告书
商品编码
1308035
未来心理健康管理The Future of Mental Health Management |
心理健康管理创新文化:补充现有治疗方法以提高疗效和可及性
儘管心理健康状况会缩短人们的寿命,但心理健康往往排在身体健康之后。在 COVID-19 大流行以及其他地缘政治局势和自然灾害导致焦虑和抑郁病例增加后,这种情况正在慢慢改变。随着认识的提高,新的治疗方法不断出现,可以补充现有的治疗方法以获得更好的效果。
心理健康问题很难治疗。这是因为单一症状有多种原因,包括环境和遗传因素,并以多种方式表现出来。因此,结合多种疗法可能会提供更好的结果,而不是使用单一疗法。心理治疗和药物治疗已经存在多年,但现在更先进的诊断和治疗技术正在导致远程医疗咨询、虚拟现实、人工智能/机器学习和症状管理的使用。事实证明,它对行动不便的人有益。进入诊所,包括使用可穿戴设备来检测并通知医护人员。这些先进技术有助于弥合护理差距,全天为患者提供服务,而不仅仅是在紧急情况下。研究人员还在研究生物标记物和其他诊断工具,这些工具可以超越传统的随时间监测症状的方法来检测精神状态。
精神药物领域也正在进行许多开发。通常用于改善大脑功能的精神药物无需医生处方即可获得。微生物组疗法和天然存在的物质也是其治疗潜力正在研究的领域。
该报告确定了该行业增长的挑战、促进因素和机会,以帮助确定增长预测。它还调查相关人员生态系统并确定值得注意的合併、收购和合作伙伴关係。最后,它详细介绍了相关人员和市场相关人员可用的融资情况。
An Innovation Culture in Mental Health Management Complements Current Therapies for Improved Efficacy and Access to Care
Mental health conditions reduce people's life expectancy-yet mental health takes a distant second place to physical health in many instances. This is slowly changing after the COVID-19 pandemic triggered rising cases of anxiety and depression, as have other geopolitical conditions and natural calamities. With rising awareness, new treatments emerge that can complement existing therapies for better outcomes.
Treating mental health issues is challenging because a condition may have varying causes, such as environmental and genetic factors, and different symptoms present themselves in different degrees. As a result, combining therapies-instead of using a single therapy-could result in better efficacy. Psychotherapy and medication have been long-standing treatment methods, and now more advanced techniques for diagnosis and treatment can prove beneficial for people with limited access to a clinic, like telehealth consultations or the use of virtual reality, artificial intelligence/machine learning, and the use of wearables for detecting a symptom and notifying a medical professional. These advanced technologies help serve patients throughout the day and not just during emergencies, which closes the gaps in care. Research is also underway for biomarkers and other diagnostic tools that can detect a mental health condition, surpassing the traditional technique of monitoring symptoms for a certain period.
Much development is also undergoing in the nootropic space. Nootropics, generally used to improve brain performance, are available without a medical prescription. Microbiome therapeutics and naturally available substances are another area being explored further for therapeutic benefits.
This Frost & Sullivan report identifies the challenges, drivers, and growth opportunities in this space and helps foresee its growth outlook. It also provides an overview of the stakeholder ecosystem, identifying notable mergers, acquisitions, and partnerships. Finally, the report provides a detailed account of the funding landscape for stakeholders and market players to leverage.